Non-invasive diagnostic imaging techniques as a window into the diabetic heart: A review of experimental and clinical data

Experimental and Clinical Endocrinology and Diabetes

Volumn 115, Issue 4, 2007, Pages 211-220

  Korosoglou, G ^a   Humpert, P M ^b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Diabetes mellitus; Diabetic cardiomyopathy; Echocardiography; Magnetic resonance imaging; Non invasive cardiac imaging; Nuclear scintigraphy

Indexed keywords

AUTONOMIC INNERVATION; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; COST BENEFIT ANALYSIS; DIABETES MELLITUS; DIAGNOSTIC IMAGING; DOPPLER ECHOGRAPHY; ECHOCARDIOGRAPHY; FIBROSING ALVEOLITIS; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HISTOPATHOLOGY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

CARDIOMYOPATHIES; CORONARY DISEASE; DIABETIC ANGIOPATHIES; HUMANS; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34248589349     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-973083     Document Type: Review

References (115)

1. Al-Shafei AI, Wise RG, Gresham GA, Bronns G, Carpenter TA, Hall LD et al. Non-invasive magnetic resonance imaging assessment of myocardial changes and the effects of angiotensin-converting enzyme inhibition in diabetic rats. J Physiol 2002a; 538: 541-553
2. Al-Shafei AI, Wise RG, Gresham GA, Carpenter TA, Hall LD, Huang CL. Magnetic resonance imaging analysis of cardiac cycle events in diabetic rats: the effect of angiotensin-converting enzyme inhibition. J Physiol 2002b; 538: 555-572
3. Allman KC, Stevens MJ, Wieland DM, Hutchins GD, Wolfe ER Jr., Greene DA et al. Noninvasive assessment of cardiac diabetic neuropathy by carbon-11 hydroxyephedrine and positron emission tomography. J Am Coll Cardiol 1993; 22: 1425-1432
4. Alvarez JA, Reyes M, Escobedo D, Freeman GL, Steinhelper ME, Feldman MD. Enhanced left ventricular systolic function early in type 2 diabetic mice: clinical implications. Diab Vasc Dis Res 2004; 1: 89-94
5. Astorri E, Fiorina P, Contini GA, Albertini D, Magnati G, Astorri A et al. Isolated and preclinical impairment of left ventricular filling in insulin-dependent and non-insulin-dependent diabetic patients. Clin Cardiol 1997; 20: 536-540
6. Attali JR, Sachs RN, Valensi P, Palsky D, Tellier P, Vulpillat M et al. Asymptomatic diabetic cardiomyopathy: a noninvasive study. Diabetes Res Clin Pract 1988; 4: 183-190
7. Backlund T, Palojoki E, Saraste A, Eriksson A, Finckenberg P, Kyto V et al. Sustained cardiomyocyte apoptosis and left ventricular remodelling after myocardial infarction in experimental diabetes. Diabetologia 2004; 47: 325-330
8. Bajraktari G, Koltai MS, Ademaj F, Rexhepaj N, Qirko S, Ndrepepa G et al. Relationship between insulin resistance and left ventricular diastolic dysfunction in patients with impaired glucose tolerance and type 2 diabetes. Int J Cardiol 2005
9. Baum VC, Levitsky LL, Englander RM. Abnormal cardiac function after exercise in insulin-dependent diabetic children and adolescents. Diabetes Care 1987; 10: 319-323
10. Bell DS. Heart failure: the frequent, forgotten, and often fatal complication of diabetes. Diabetes Care 2003; 26: 2433-2441
11. Bertoni AC, Goff DC Jr., D'Agostino RB Jr., Liu K, Hundley WG, Lima JA et al. Diabetic cardiomyopathy and subclinical cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 2006; 29: 588-594
12. 2+-ATPase. Diabetes 2004; 53: 463-473
13. Bierhaus A, Schiekofer S, Schwaninger M, Andrassy M, Humpert PM, Chen J et al. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 2001; 50: 2792-2808
14. Bittner V, Weiner DH, Yusuf S, Rogers WJ, McIntyre KM, Bangdiwala SI et al. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators. Jama 1993; 270: 1702-1707
15. Bohler S, Glaesmer H, Pittrow D, Lehnert H, Stalla GK, Zeiher AM et al. Diabetes and cardiovascular risk evaluation and management in primary care: progress and unresolved issues - rationale for a nationwide primary care project in Germany. Exp Clin Endocrinol Diabetes 2004; 112: 157-170
16. Bourassa MG, Gurne O, Bangdiwala SI, Ghali JK, Young JB, Rousseau M et al. Natural history and patterns of current practice in heart failure. The Studies of Left Ventricular Dysfunction (SOLVD) Investigators. J Am Coll Cardiol 1993; 22: 14A-19A
17. Boyer JK, Thanigaraj S, Schechtman KB, Perez JE. Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. Am J Cardiol 2004; 93: 870-875
18. Carlstrom S, Karlefors T. Haemodynamic studies on newly diagnosed diabetics before and after adequate insulin treatment. Br Heart J 1970; 32: 355-358
19. Chatham JC, Forder JR. Relationship between cardiac function and substrate oxidation in hearts of diabetic rats. Am J Physiol 1997; 273: H52-8
20. Chen V, Ianuzzo CD, Fong BC, Spitzer JJ. The effects of acute and chronic diabetes on myocardial metabolism in rats. Diabetes 1984; 33: 1078-1084
21. Chung J, Abraszewski P, Yu X, Liu W, Krainik AJ, Ashford M et al. Paradoxical increase in ventricular torsion and systolic torsion rate in type I diabetic patients under tight glycemic control. J Am Coll Cardiol 2006; 47: 384-390
22. Daoud S, Schinzel R, Neumann A, Loske C, Fraccarollo D, Diez C et al. Advanced glycation endproducts: activators of cardiac remodeling in primary fibroblasts from adult rat hearts. Mol Med 2001; 7: 543-551
23. DeMaria AN, Wisenbaugh TW, Smith MD, Harrison MR, Berk MR. Doppler echocardiographic evaluation of diastolic dysfunction. Circulation 1991; 84: 1288-95
24. Dent CL, Bowman AW, Scott MJ, Allen JS, Lisauskas JB, Janif M et al. Echocardiographic characterization of fundamental mechanisms of abnormal diastolic filling in diabetic rats with a parameterized diastolic filling formalism. J Am Soc Echocardiogr 2001; 14: 1166-1172
25. Diamant M, Lamb HJ, Groeneveld Y, Endert EL, Smit JW, Bax JJ et al. Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J Am Coll Cardiol 2003; 42: 328-335
26. Dirksen MS, Bax JJ, de Roos A, Jukema JW, van der Geest RJ, Geleijns K et al. Usefulness of dynamic multislice computed tomography of left ventricular function in unstable angina pectoris and comparison with echocardiography. Am J Cardiol 2002; 90: 1157-1160
27. Dumesnil JG, Gaudreault G, Honos GN, Kingma JG Jr. Use of Valsalva maneuver to unmask left ventricular diastolic function abnormalities by Doppler echocardiography in patients with coronary artery disease or systemic hypertension. Am J Cardiol 1991; 68: 515-519
28. Edvardsen T, Gerber BL, Garot J, Bluemke DA, Lima JA, Smiseth OA. Quantitative assessment of intrinsic regional myocardial deformation by Doppler strain rate echocardiography in humans: validation against three-dimensional tagged magnetic resonance imaging. Circulation 2002; 106: 50-56
29. Factor SM, Bhan R, Minase T, Wolinsky H, Sonnenblick EH. Hypertensive-diabetic cardiomyopathy in the rat: an experimental model of human disease. Am J Pathol 1981; 102: 219-228
30. Factor SM, Minase T, Sonnenblick EH. Clinical and morphological features of human hypertensive-diabetic cardiomyopathy. Am Heart J 1980; 99: 446-458
31. Fang ZY, Leano R, Marwick TH. Relationship between longitudinal and radial contractility in subclinical diabetic heart disease. Clin Sci (Lond) 2004a; 106: 53-60
32. Fang ZY, Najos-Valencia O, Leano R, Marwick TH. Patients with early diabetic heart disease demonstrate a normal myocardial response to dobutamine. J Am Coll Cardiol 2003; 42: 446-453
33. Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 2004b; 25: 543-567
34. Fava S, Azzopardi J, Muscat HA, Fenech FF. Factors that influence outcome in diabetic subjects with myocardial infarction. Diabetes Care 1993; 16: 1615-1618
35. Fischer SE, McKinnon GC, Maier SE, Boesiger P. Improved myocardial tagging contrast. Magn Reson Med 1993; 30: 191-200
36. Fonseca CG, Dissanayake AM, Doughty RN, Whalley GA, Gamble CD, Cowan BR et al. Three-dimensional assessment of left ventricular systolic strain in patients with type 2 diabetes mellitus, diastolic dysfunction, and normal ejection fraction. Am J Cardiol 2004; 94: 1391-1395
37. Friedman NE, Levitsky LL, Edidin DV, Vitullo DA, Lacina SJ, Chiemmongkoltip P. Echocardiographic evidence for impaired myocardial performance in children with type I diabetes mellitus. Am J Med 1982; 73: 846-850
38. Ganguly PK, Thliveris JA, Mehta A. Evidence against the involvement of nonenzymatic glycosylation in diabetic cardiomyopathy. Metabolism 1990; 39: 769-773
39. Garcia MJ, Thomas JD, Klein AL. New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol 1998; 32: 865-875
40. Garvey WT, Hardin D, Juhaszova M, Dominguez JH. Effects of diabetes on myocardial glucose transport system in rats: implications for diabetic cardiomyopathy. Am J Physiol 1993; 264: H837-44
41. Giacomelli F, Wiener J. Primary myocardial disease in the diabetic mouse. An ultrastructural study. Lab Invest 1979; 40: 460-473
42. Gotzsche O, Darwish A, Gotzsche L, Hansen LP, Sorensen KE. Incipient cardiomyopathy in young insulin-dependent diabetic patients: a seven-year prospective Doppler echocardiographic study. Diabet Med 1996; 13: 834-840
43. Grandi AM, Piantanida E, Franzetti I, Bernasconi M, Maresca A, Marnini P et al. Effect of glycemic control on left ventricular diastolic function in type 1 diabetes mellitus. Am J Cardiol 2006; 97: 71-76
44. Hartmann F, Ziegler S, Nekolla S, Hadamitzky M, Seyfarth M, Richardt G et al. Regional patterns of myocardial sympathetic denervation in dilated cardiomyopathy: an analysis using carbon-11 hydroxyephedrine and positron emission tomography. Heart 1999; 81: 262-270
45. Hayashi K, Okumura K, Matsui H, Murase K, Kamiya H, Saburi Y et al. Involvement of 1,2-diacylglycerol in improvement of heart function by etomoxir in diabetic rats. Life Sci 2001; 68: 1515-1526
46. Hoit BD, Castro C, Bultron G, Knight S, Matlib MA. Noninvasive evaluation of cardiac dysfunction by echocardiography in streptozotocin-induced diabetic rats. J Card Fail 1999; 5: 324-333
47. Hsu KL, Chiang FT, Lo HM, Tsai CH, Tseng CD, Tseng YZ. Cardiac contractility in noninsulin dependent diabetes mellitus evaluated using the relation between endsystolic wall stress and velocity of circumferential fiber shortening. Jpn Heart J 1997; 38: 463-471
48. Hutchins GD, Chen T, Carlson KA, Fain RL, Winkle W, Vavrek T et al. PET imaging of oxidative metabolism abnormalities in sympathetically denervated canine myocardium. J Nucl Med 1999; 40: 846-853
49. Jackson CV, McGrath GM, Tahiliani AG, Vadlamudi RV, McNeill JH. A functional and ultrastructural analysis of experimental diabetic rat myocardium. Manifestation of a cardiomyopathy. Diabetes 1985; 34: 876-883
50. Joffe II, Trovers KE, Perreault-Micale CL, Hampton T, Katz SE, Morgan JP et al. Abnormal cardiac function in the streptozotocin-induced non-insulin-dependent diabetic rat: noninvasive assessment with doppler echocardiography and contribution of the nitric oxide pathway. J Am Coll Cardiol 1999; 34: 2111-2119
51. Juergens KU, Grude M, Maintz D, Fallenberg EM, Wichter T, Heindel W et al. Multi-detector row CT of left ventricular function with dedicated analysis software versus MR imaging: initial experience. Radiology 2004; 230: 403-410
52. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 1979; 2: 120-126
53. Karvounis HI, Papadopoulos CE, Zaglavara TA, Nouskas IG, Gemitzis KD, Parharidis GE et al. Evidence of left ventricular dysfunction in asymptomatic elderly patients with non-insulin-dependent diabetes mellitus. Angiology 2004; 55: 549-555
54. Kawaguchi M, Techigawara M, Ishihata T, Asakura T, Saito F, Maehara K et al. A comparison of ultrastructural changes on endomyocardial biopsy specimens obtained from patients with diabetes mellitus with and without hypertension. Heart Vessels 1997; 12: 267-274
55. Korosoglou G, Humpert PM, Halbgewachs E, Bierhaus A, Katus H, Nawroth PP et al. Evidence of Left Ventricular Contractile Asynchrony in Asymptomatic Patients with Type II Diabetes. AJ Cardiol 2006; 98: 1525-1530
56. Kosmala W, Kucharski W, Przewlocka-Kosmala M, Mazurek W. Comparison of left ventricular function by tissue Doppler imaging in patients with diabetes mellitus without systemic hypertension versus diabetes mellitus with systemic hypertension. Am J Cardiol 2004; 94: 395-399
57. Kozak-Barany A, Jokinen E, Kero P, Tuominen J, Ronnemaa T, Valimaki I. Impaired left ventricular diastolic function in newborn infants of mothers with pregestational or gestational diabetes with good glycemic control. Early Hum Dev 2004; 77: 13-22
58. Lainchbury JG, Redfield MM. Doppler echocardiographic-guided diagnosis and therapy of heart failure. Curr Cardiol Rep 1999; 1: 55-66
59. Liedtke AJ, DeMaison L, Eggleston AM, Cohen LM, Nellis SH. Changes in substrate metabolism and effects of excess fatty acids in reperfused myocardium. Circ Res 1988; 62: 535-542
60. Linnemann B, Janka HU. Prolonged QTc interval and elevated heart rate identify the type 2 diabetic patient at high risk for cardiovascular death. The Bremen Diabetes Study. Exp Clin Endocrinol Diabetes 2003; 111: 215-222
61. Loganathan R, Bilgen M, Al-Hafez B, Smirnova IV. Characterization of alterations in diabetic myocardial tissue using high resolution MRI. Int J Cardiovasc Imaging 2006; 22: 81-90
62. Mahnken AH, Koos R, Katoh M, Spuentrup E, Busch P, Wildberger JE et al. Sixteen-slice spiral CT versus MR imaging for the assessment of left ventricular function in acute myocardial infarction. Eur Radiol 2005; 15: 714-720
63. Mahnken AH, Spuentrup E, Niethammer M, Buecker A, Boese J, Wildberger JE et al. Quantitative and qualitative assessment of left ventricular volume with ECG-gated multislice spiral CT: value of different image reconstruction algorithms in comparison to MRI. Acta Radiol 2003; 44: 604-611
64. Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 1995; 26: 57-65
65. Mantysaari M, Kuikka J, Mustonen J, Tahvanainen K, Vanninen E, Lansimies E et al. Noninvasive detection of cardiac sympathetic nervous dysfunction in diabetic patients using [123I]metaiodobenzylguanidine. Diabetes 1992; 41: 1069-1075
66. Mantysaari M, Kuikka J, Mustonen J, Tahvanainen K, Vanninen E, Lansimies E et al. Measurement of myocardial accumulation of 123I-metaiodobenzylguanidine for studying cardiac autonomic neuropathy in diabetes mellitus. Clin Auton Res 1996; 6: 163-169
67. Marantz PR, Tobin JN, Wassertheil-Smoller S, Steingart RM, Wexler JP, Budner N et al. The relationship between left ventricular systolic function and congestive heart failure diagnosed by clinical criteria. Circulation 1988; 77: 607-612
68. Maser RE, Mitchell BD, Vinik AI, Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care 2003; 26: 1895-1901
69. Matsumoto Y, Kaneko M, Kobayashi A, Fujise Y, Yamazaki N. Creatine kinase kinetics in diabetic cardiomyopathy. Am J Physiol 1995; 268: E1070-6
70. Matsumura Y, Elliott PM, Virdee MS, Sorajja P, Doi Y, McKenna WJ. Left ventricular diastolic function assessed using Doppler tissue imaging in patients with hypertrophic cardiomyopathy: relation to symptoms and exercise capacity. Heart 2002; 87: 247-251
71. Mbanya JC, Sobngwi E, Mbanya DS, Ngu KB. Left ventricular mass and systolic function in African diabetic patients: association with microalbuminuria. Diabetes Metab 2001; 27: 378-382
72. McKelvie RS, Yusuf S, Pericak D, Avezum A, Burns RJ, Probstfield J et al. Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators. Circulation 1999; 100: 1056-1064
73. Metzler B, Schocke MF, Steinboeck P, Wolf C, Judmaier W, Lechleitner M et al. Decreased high-energy phosphate ratios in the myocardium of men with diabetes mellitus type I. J Cardiovasc Magn Reson 2002; 4: 493-502
74. Miyanaga H, Yoneyama S, Kamitani T, Kawasaki S, Takahashi T, Kunishige H. Clinical usefulness of 123I-metaiodobenzylguanidine myocardial scintigraphy in diabetic patients with cardiac sympathetic nerve dysfunction. Jpn Circ J 1995; 59: 599-607
75. Mizushige K, Yao L, Noma T, Kiyomoto H, Yu Y, Hosomi N et al. Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model. Circulation 2000; 101: 899-907
76. Murata K, Sumida Y, Murashima S, Matsumura K, Takeda H, Nakagawa T et al. A novel method for the assessment of autonomic neuropathy in type 2 diabetic patients: a comparative evaluation of 123I-MIBG myocardial scintigraphy and power spectral analysis of heart rate variability. Diabet Med 1996; 13: 266-272
77. Nagamachi S, Jinnouchi S, Nakahara H, Flores LG 2nd, Ohnishi T, Hoshi H et al. 123I-MIBG myocardial scintigraphy in diabetic patients: relationship to autonomic neuropathy. Nucl Med Commun 1996; 17: 621-632
78. Nichols GA, Hillier TA, Erbey JR, Brown JB. Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors. Diabetes Care 2001; 24: 1614-1619
79. Nugent AM, Steele IC, al-Modaris F, Vallely S, Moore A, Campbell NP et al. Exercise responses in patients with IDDM. Diabetes Care 1997; 20: 1814-1821
80. Poirier P, Bogaty P, Garneau C, Marois L, Dumesnil JG. Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care 2001; 24: 5-10
81. Pop-Busui R, Kirkwood I, Schmid H, Marinescu V, Schroeder J, Larkin D et al. Sympathetic dysfunction in type 1 diabetes: association with impaired myocardial blood flow reserve and diastolic dysfunction. J Am Coll Cardiol 2004; 44: 2368-2374
82. Raggi P. Role of electron-beam computed tomography and nuclear stress testing in cardiovascular risk assessment. Am J Cardiol 2005; 96: 20J-27J
83. Rathmann W, Ziegler D, Jahnke M, Haastert B, Gries FA. Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Med 1993; 10: 820-824
84. Regan TJ, Lyons MM, Ahmed SS, Levinson GE, Oldewurtel HA, Ahmad MR et al. Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest 1977; 60: 884-899
85. Riordan MM, Chung CS, Kovacs SJ. Diabetes and diastolic function: Stiffness and relaxation from transmittal flow. Ultrasound Med Biol 2005; 31: 1589-1596
86. Riordan MM, Kovacs SJ. Quantitation of mitral annular oscillations and longitudinal "ringing" of the left ventricle: a new window into longitudinal diastolic function. J Appl Physiol 2006; 100: 112-119
87. Robillon JF, Sadoul JL, Jullien D, Morand P, Freychet P. Abnormalities suggestive of cardiomyopathy in patients with type 2 diabetes of relatively short duration. Diabete Metab 1994; 20: 473-480
88. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 1972; 30: 595-602
89. Rumberger JA, Simons DB, Fitzpatrick LA, Sheedy PF, Schwartz RS. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation 1995; 92: 2157-2162
90. Salazar J, Rivas A, Rodriguez M, Felipe J, Garcia MD, Bone J. Left ventricular function determined by Doppler echocardiography in adolescents with type I (insulin-dependent) diabetes mellitus. Acta Cardiol 1994; 49: 435-439
91. Saraiva RM, Duarte DM, Duarte MP, Martins AF, Poltronieri AV, Ferreira ME et al. Tissue Doppler imaging identifies asymptomatic normotensive diabetics with diastolic dysfunction and reduced exercise tolerance. Echocardiography 2005; 22: 561-570
92. Schaible TF, Malhotra A, Bauman WA, Scheuer J. Left ventricular function after chronic insulin treatment in diabetic and normal rats. J Mol Cell Cardiol 1983; 15: 445-458
93. Schannwell CM, Schneppenheim M, Perings S, Plehn G, Strauer BE. Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy. Cardiology 2002; 98: 33-39
94. Scheuermann-Freestone M, Madsen PL, Manners D, Blamire AM, Buckingham RE, Styles P et al. Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation 2003; 107: 3040-3046
95. Schmid H, Forman LA, Cao X, Sherman PS, Stevens MJ. Heterogeneous cardiac sympathetic denervation and decreased myocardial nerve growth factor in streptozotocin-induced diabetic rats: implications for cardiac sympathetic dysinnervation complicating diabetes. Diabetes 1999; 48: 603-608
96. Schnell O, Kirsch CM, Stemplinger J, Haslbeck M, Standl E. Scintigraphic evidence for cardiac sympathetic dysinnervation in long-term IDDM patients with and without ECG-based autonomic neuropathy. Diabetologia 1995; 38: 1345-1352
97. Schnell O, Muhr D, Weiss M, Dresel S, Haslbeck M, Standl E. Reduced myocardial 123I-metaiodobenzylguanidine uptake in newly diagnosed IDDM patients. Diabetes 1996; 45: 801-805
98. Schuijf JD, Bax JJ, Jukema JW, Lamb HJ, Vliegen HW, Salm LP et al. Noninvasive angiography and assessment of left ventricular function using multislice computed tomography in patients with type 2 diabetes. Diabetes Care 2004; 27: 2905-2910
99. Semeniuk LM, Kryski AJ, Severson DL. Echocardiographic assessment of cardiac function in diabetic db/db and transgenic db/db-hGLUT4 mice. Am J Physiol Heart Circ Physiol 2002; 283: H976-82
100. Sohn DW, Chai IH, Lee DJ, Kim HC, Kim HS, Oh BH et al. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 1997; 30: 474-480
101. SOLVD-Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med 1991; 325: 293-302
102. Stevens MJ, Dayanikli F, Raffel DM, Allman KC, Sandford T, Feldman EL et al. Scintigraphic assessment of regionalized defects in myocardial sympathetic innervation and blood flow regulation in diabetic patients with autonomic neuropathy. J Am Coll Cardiol 1998a; 31: 1575-1584
103. Stevens MJ, Raffel DM, Allman KC, Dayanikli F, Ficaro E, Sandford T et al. Cardiac sympathetic dysinnervation in diabetes: implications for enhanced cardiovascular risk. Circulation 1998b; 98: 961-968
104. Struthers AD, Morris AD. Screening for and treating left-ventricular abnormalities in diabetes mellitus: a new way of reducing cardiac deaths. Lancet 2002; 359: 1430-1432
105. Suskin N, McKelvie RS, Burns RJ, Latini R, Pericak D, Probstfield J et al. Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. Eur Heart J 2000; 21: 1368-1375
106. Suys BE, Katier N, Rooman RP, Matthys D, Op De Beeck L, Du Caju MV et al. Female children and adolescents with type 1 diabetes have more pronounced early echocardiographic signs of diabetic cardiomyopathy. Diabetes Care 2004; 27: 1947-1953
107. Taskiran M, Rasmussen V, Rasmussen B, Fritz-Hansen T, Larsson HB, Jensen GB et al. Left ventricular dysfunction in normotensive Type 1 diabetic patients: the impact of autonomic neuropathy. Diabet Med 2004; 21: 524-530
108. Trost SU, Belke DD, Bluhm WF, Meyer M, Swanson E, Dillmann WH. Overexpression of the sarcoplasmic reticulum Ca(2+)-ATPase improves myocardial contractility in diabetic cardiomyopathy. Diabetes 2002; 51: 1166-1171
109. Turpeinen AK, Vanninen E, Kuikka JT, Uusitupa MI. Demonstration of regional sympathetic denervation of the heart in diabetes. Comparison between patients with NIDDM and IDDM. Diabetes Care 1996; 19: 1083-1090
110. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2003; 26: 1553-1579
111. Von Bibra H, Thrainsdottir IS, Hansen A, Dounis V, Malmberg K, Ryden L. Tissue Doppler imaging for the detection and quantitation of myocardial dysfunction in patients with type 2 diabetes mellitus. Diab Vasc Dis Res 2005; 2: 24-30
112. von Bibra H, Tuchnitz A, Klein A, Schneider-Eicke J, Schomig A, Schwaiger M. Regional diastolic function by pulsed Doppler myocardial mapping for the detection of left ventricular ischemia during pharmacologic stress testing: a comparison with stress echocardiography and perfusion scintigraphy. J Am Coll Cardiol 2000; 36: 444-452
113. Witteles RM, Tang WH, Jamali AH, Chu JW, Reaven GM, Fowler MB. Insulin resistance in idiopathic dilated cardiomyopathy: a possible etiologic link. J Am Coll Cardiol 2004; 44: 78-81
114. Zanzonico P, Rothenberg LN, Strauss HW. Radiation exposure of computed tomography and direct intracoronary angiography: risk has its reward. J Am Coll Cardiol 2006; 47: 1846-1849
115. Ziegler D, Weise F, Langen KJ, Piolot R, Boy C, Hubinger A et al. Effect of glycaemic control on myocardial sympathetic innervation assessed by [123I]metaiodobenzylguanidine scintigraphy: a 4-year prospective study in IDDM patients. Diabetologia 1998; 41: 443-451